Abstract: A number of epidemiologic studies on organochlorines (OCs) and breast cancer risk have been published. The majority (n = 18) measured OCs in adipose tissue, primarily from mammary biopsies in cancer cases and controls with benign breast disease, and studied incident disease. Seven of these studies each included fewer than 50 cases and controls and had limited capacity for covariate adjustment. Eleven studies used serum samples collected from 6 months to 25 years prior to diagnosis. An additional 13 studies (2 with some overlap) used serum collected at or after diagnosis. Regardless of the medium used to measure OC levels, studies conducted to date do not provide consistent evidence that any of the OCs examined thus far play a role in the initial breast cancer risk. This paper provides a compound specific review with discussion of how the lack of evidence for adverse effects might be explained by factors related to study design, or by variation in risk across subgroups.
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See [57] See [57] See [57] See [57] See [57] See [57] See [57] See [57] See [57] See [57] See [34] See [22] See [22] See [22] See [22] PCBs: Conversions/estimates: mcg/kg = ng/g; mg/kg × 1000 = ng/g; mcg/g × 1000 = ng/g. Wet wt: ppb = ng/ml; ppm × 1000 = ng/ml. Midpoints used to estimate medians when not given. Table 1 and detailed below, regardless of the medium used to measure OC levels, studies conducted to date do not provide consistent evidence that any of the OCs examined thus far play a role in the initial breast cancer risk. A compound-specific review follows with discussion of how the lack of evidence for adverse effects might be explained by factors related to study design, or by variation in risk across subgroups.
DDT/DDE
p,p′-DDT is only weakly estrogenic, but persists in the food chain [2, 11, 13] . Of 10 studies reporting multivariate-adjusted ORs, only one [31] found elevated risk associated with adipose or serum levels of p,p′-DDT (Table 2) . Another eight studies compared mean levels of p,p′-DDT but incorporated limited covariate adjustment. One of these [32] reported significantly higher levels in cases, after adjusting for age and BMI. o,p′-DDT-a more estrogenic but less persistent isomer-has not been studied epidemiologically because even studies using serum collected in the 1970s, when levels were higher, had too few participants with detectable levels to analyze associations separately [33] . A number of studies [31, [33] [34] [35] [36] [37] examined associations with total DDT, estimated as the sum of p,p′-DDT and several metabolites. None reported evidence of adverse effects in relation to high levels of the sum of these DDT metabolites.
Most studies of DDE have examined p,p′-DDE, the main persistent metabolite of DDT. Since this compound, which is not estrogenic, is found in foods, elevated levels may not be the result of direct exposure to p,p′-DDT [11, 37, 38] . Although a few studies conducted from 1992 to 1994 [29, 39] , in ER positive [ER+] tumors; [40] suggested possible increased risk associated with p,p′-DDE, other early exploratory studies did not find increased risk [41, 42] , and the majority of studies since that time have reported inverse or null associations (Table 3) . Two of the three initial studies reporting elevated p,p′-DDE in subjects with breast cancer were very small (≤20 cases) and unable to conduct adequate multivariate adjustment [29, 39] . Positive associations reported by [40] were based on cases diagnosed within 6 months of serum collection and were not confirmed in a follow-up using cases with similar OC levels, diagnosed >6 months after enrollment [25] . Adjustment for serum lipids, omitted in the first analysis, did not influence results of the second study.
To date, 27 moderate to large (i.e., at least 50 cases) studies with multivariate adjustment have explored associations between p,p′-DDE and breast cancer. Other than the early studies referenced above, only one other study ([23] in a Mexico City study of parous women) has reported significant positive associations overall. Two additional studies reported significant positive associations in different subgroups ( [43] in ER negative [ER-] tumors; [30] in blacks but not whites or Hispanics). One small study [44] , using adipose tissue samples collected from 1987 to 1989 and analyzed without adjustments did report significantly higher means of the more estrogenic but short-lived metabolite o,p′-DDE in cases than controls.
In summary, the majority of studies, regardless of medium or study size, showed no negative impact of DDT or DDE on risk of breast cancer. Risk was not more likely to be apparent in populations with higher mean concentrations of DDT or DDE. In fact, many studies show risk ratios below 1, as above 1 (as seen on Figs. 1a and 1b). Other notes: Zheng [57] are age-and lipid-adjusted means; Wolff [53] : Results similar for blacks, hispanics, and whites. Other notes: Stellman [32] are age/BMI-adjusted means. Zheng [57] are age-and lipid-adjusted means. 
PCBs
Four of 17 published studies on total PCBs and breast cancer risk reported significant positive associations (Table 4 ). The report of Wolff et al. [40] showed a significant positive association that was not replicated in the follow-up study [25] . In the three other studies, elevated risk was limited to various diverse population subgroups (Moysich et al. [22] in parous never-lactators; Millikan et al. [45] in blacks, particularly if obese; Laden et al. [46] in nulliparous women). Examining total PCBs may mask variation in congener-specific effects, as some of the 209 congeners are thought to be estrogenic (type 1a), while others appear to be antiestrogenic (types 2a and b), or to have no estrogenic activity (type 1b, based on groupings proposed by Wolff and Toniolo [8] ; Wolff et al. [47] ). Net effects of PCB mixtures may vary depending on relative concentrations of these different congeners [47, 48] . The low-chlorination, potentially estrogenic congeners of group 1a are not persistent, as they are readily metabolized and eliminated [48] . However, the two studies [44, 49] reporting means for congeners in this group did not find significant differences between cases and controls (Table 5 ). Given their rapid elimination, retrospective studies may not be reliable for assessing any longterm effects of these congeners. The prospective studies have had few subjects with detectable levels of 1a congeners [33] . [29, 32, 43, 49] ).
Congeners in group 2a are thought to be antiestrogenic and immunotoxic; those in group 2b appear to have limited dioxin activity. The highly persistent congeners in group 3 are thought to induce cytochrome P450 and phenobarbital activity. No studies have reported elevated risk associated with the sum of the congeners from these groups. A few studies have reported elevated risk associated with individual congeners in each group (e.g., PCBs 118, 138, 99), but results have been inconsistent (Table 5) .
Two studies compared PCB congeners classified as high-vs. low-chlorination in relation to breast cancer and again found ambiguous results. Wolff et al. [53] reported evidence of elevated risk only for low-chlorination congeners. In contrast, Millikan et al. [45] reported greater risk associated with highchlorination congeners.
Other OCs
The few studies examining other OCs in relation to breast cancer risk have, for the most part, found no association (Table 6 ). No studies have reported significant increased risk associated with chlordane metabolites, including cis-nonachlor (CN), trans-nonachlor (TN), oxychlordane (OXY), and heptachlor epoxide (HCE) [24, 43, [50] [51] [52] [53] [54] . Mixed results have been reported for dieldrin, mirex, HCB, and HCH (or b-BHC; see Table 6 ). No studies on endosulfan were found.
STUDY DESIGN FACTORS

Adipose tissue vs. blood
As OCs are lipophilic, adipose tissue sample stores are thought to provide a better index of long-term exposure than blood-based measures. Strong correlations between adipose tissue and lipid-adjusted serum levels of DDE have been reported in some (r = 0.8, [55] ) but not all (r = 0.4, [64] ) studies. Similar, low correlations between adipose and lipid-adjusted serum levels of PCBs have been seen (e.g., r = 0.4 for PCB 153; [55] ).
Differences in these measures do not, however, appear to explain study inconsistencies, as results using each medium have been heterogeneous. For example, significant positive associations with DDE and breast cancer were reported for: (i) one of six reports from large studies using adipose tissue samples; (ii) two of 10 studies using prospective serum samples; and (iii) none of 10 studies based on retrospective serum (Table 2) .
Study populations-using benign breast disease (BBD) controls
Most studies based on adipose tissue used BBD patients as controls because it is more difficult to obtain adipose tissue samples from disease-free subjects (Table 1) . If OCs contribute to the risk of BBD, this strategy may bias results toward the null. However, studies using alternative control groups also failed to observe positive associations. Using patients presenting for breast reduction surgery, Bagga et al. [34] found null associations for various DDTs. Inverse associations with DDE were reported by van't Veer et al. [56] in a study based on gluteal adipose tissue samples and population-based controls. Studies that excluded [57] [58] [59] [60] or limited [32] the proportion of BBD controls with evidence of atypia found no strong evidence of adverse effects. Wolff et al. [53] also found no difference in results between BBD and non-BBD non-cancer controls, suggesting that the predominance of BBD controls is not the reason for lack of a measurable detrimental effect. Table 6 Other organochlorines and breast cancer. Other notes: Moysich [22] found elevated ns ORs for HCB only in parous women who never lactated. Zheng [52, 58, 59] are age-and lipid-adjusted means.
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Hoyer [36] -Results not shown for mirex, aldrin, endrin, AC, YC, heptachlor, heptachlor oxide, OCD, TN, y-HCH, HCB-presumed NS. 
Timing of exposure measurement vs. use of OC chemicals
The majority of studies in industrialized countries have measured OC residues in biological samples collected from adults in the 1980s and 1990s, well after most source chemicals were banned. Given half-life estimates on the order of 7 to 11 years for DDE and PCBs [53] , residues measured in these studies may largely reflect exposure to persistent but less estrogenic OCs (such as p,p′-DDE and highchlorination PCB congeners), rather than long-term exposure to estrogenic but less persistent compounds such as DDT, dieldrin, and low-chlorination PCBs [11, 13, 48] . Therefore, recent measures of OCs may not be good estimates of past exposure to estrogenic compounds. Direct estimates using samples obtained closer to the period when chemical sources remained in use should be more reliable for identifying any adverse effects of less persistent OCs, as long as samples were stable and analytic measures were sensitive enough. In industrialized countries, four of five prospective studies used blood collected as early as the 1960s and 1970s. These did not find overall adverse effects of DDTs, PCBs, or several other OCs [24, 30, 33, 35] . Concentrations of DDE and DDT in these samples were relatively high (Tables 2 and 3 ). The one study showing effects that examined p,p′-DDT in a population-based Danish study [31] used repeated serum measures and adjusting for weight change. No other studies have incorporated repeated measures of OC exposure, and few have included measures of weight change (see Table 1 ).
Of the studies examining associations between DDT, DDE, and breast cancer risk in countries where use of DDT continues (Table 2) , some based in Mexico City [23, 61] and in Vietnam [37] found lower mean levels of p,p′-DDT in breast cancer cases vs. controls. No association between DDE and breast cancer in hospital-based case-control studies were noted in Vietnam [37] , Mexico City [61] , or in a population-based study in Brazil [62] . An anomalous result was seen in a population-based study of parous women in Mexico City [23] that reported strong and significant positive associations with DDT-adjusted levels of serum DDE. The authors hypothesized that adjusting for DDT provided better estimates of long-vs. short-term exposure to DDE. It is not clear whether they limited their adjustment model to low-persistence DDT isomers. Without this adjustment, multivariate associations were not significant (OR for highest vs. lowest quartile 2.16, CI 0.85-5.50 vs. 3.81, CI 1.14-2.8).
It is surprising that, although timeframes for the Mexico City studies overlapped (1990 to 1995 for Romieu et al. [23] ; 1994 to 1996 for Lopez-Carillo et al. [61] ), serum DDE was five times higher in the study reporting positive associations (lipid-adjusted means in cases/controls were 3840/2510 vs. 563/506 nanograms per gram [ng/g]). It is not clear to what extent discrepancies between the two Mexico City studies may reflect true differences in DDT and DDE exposure, metabolism, temporal changes, or differences in laboratory techniques.
Mobilization and elimination of OCs-weight change, adiposity, and lactation tion status increased coefficients for DDE exposure by 57 % (from 0.051 ± 0.022 to 0.080 ± 0.030). Limited data also suggest that higher DDE is associated with reduced duration of breastfeeding [67] , and several studies found that OCs were associated with higher risk of breast cancer among nulliparous women, or parous women who never breastfed than lactators ([22]-HCB; [50] -Mirex; [45, 46] -total PCBs; [54] -chlordane). These findings are consistent with the hypothesis that breastfeeding may help to reduce the OC burden during a period of increased susceptibility to breast cancer.
Dietary confounders
Few studies have included dietary covariates (see Table 1 ). Dietary fat may be a confounder, given that fat-containing foods are important sources of exposure to persistent OC metabolites [3] . However, results of studies that adjusted for fat intakes did not differ from those that did not [50, 52, [57] [58] [59] . Furthermore, the role of dietary fat in breast cancer is unclear [68] . Dietary phytoestrogens may modify or confound associations, perhaps by inhibiting estrogenic action of OCs [69, 70] A number of dietary phytoestrogens (e.g., genistein) appear to be more potent estrogens than typical OCs [71] . No studies to date have reported accounting for dietary phytoestrogens, whose role in breast cancer etiology is also uncertain [72, 73] .
Consideration of adjustment for these variables is essential for approximating cumulative or past exposure based on single measures of OC residues. While most studies have adjusted for BMI, few have accounted for lactation history or weight change (see Table 1 for details) [29, 31, 35, 56] . No study has simultaneously considered all three factors.
POSSIBLE HIGH-RISK SUBGROUPS
Menopausal status: It has been suggested that postmenopausal women because of low circulating estrogen levels may be more susceptible to risk factors that influence the hormonal milieu [72] . A few studies have observed stronger associations in post-menopausal than in pre-menopausal women for DDT ( [23] for DDT) or total PCBs ( [49] , especially if ER+). The majority of studies have not found strong associations among postmenopausal women for DDT/DDE [22, 25, 30, 32, 33, 45, 49, 50, 53, 54, 56, 57, 60, 61, 74] , total PCBs [22, 25, 32, 45, 53, 60] or other OCs such as HCB, mirex, and chlordane metabolites [22, 40, 50, 52, 54, 58, 59 ]. In fact, several studies found stronger associations among premenopausal than postmenopausal women for DDE [35] , total PCBs [35] , and selected PCB congeners [50] .
Assessing the significance of any differences in risk by menopausal status is complicated by differences in exposure patterns of younger vs. older women. A cohort effect in older women having experienced greater childhood and lifetime exposures may be responsible for what might be considered an age-related or lifetime accumulation effect when compared with younger women. Among younger women, whose exposure during peak use of these chemicals was limited to childhood and adolescence, adult OC residues may largely reflect ongoing food-borne exposure to persistent metabolites. Direct exposure to industrial and agricultural chemicals in the past likely explains why OC levels are higher in older than in younger women (e.g., [27] ). However, exposure in postmenopausal women may have been qualitatively different from that in younger women: during peak chemical use in the 1950s and 1960s, these women were adults.
ER status
Consistent with the hypothesis that the hormones may be more involved in the etiology of ER+ than ER-tumors [75] , Dewailly et al. [29] found that DDE, PCB 99, and trans-nonachlor were associated with ER+ but not ER-tumors (see Tables 3, 4 , and 7). Liljegren et al. [49] also found significantly higher risk associated with HCB and several PCBs (77, 126, 169) among ER+ tumors, especially in postmenopausal women. Other studies have not confirmed these findings. Woolcott et al. [43] found somewhat stronger associations between DDE, total PCBs, trans-nonachlor, b-HCH, and several PCB congeners in ER-tumors (see Tables 3-5) . Although Helzsouer et al. [35] found higher associations with DDE in ER+ tumors using serum collected in 1989, associations were higher in ER-tumors using serum from 1974. Numerous studies reported similar associations with DDE [24, 25, 45, 49, [52] [53] [54] 74] , PCBs [24, 25, 35, 45, [52] [53] [54] 60, 74] , and other OCs [43, 52, 54, 58, 59 ] regardless of ER status.
Ethnicity and threshold effects: Krieger et al. [30] and Millikan et al. [45] reported somewhat stronger associations between serum DDE, total PCBs, and breast cancer risk among African Americans than other ethnic groups (whites and Asians). They hypothesized that the higher associations might be attributable at least in part to higher exposure levels. Yet there were no differences in associations among African Americans, whites, and Hispanics in a report by Wolff et al. [53] , in which OC levels were similarly elevated among blacks. There was also no association with breast cancer risk in other studies in whites with similar serum OC levels [25, 35] . However, associations between breast cancer and DDE were significant in the studies with the highest serum levels [23] , after adjustment for DDT) and adipose levels [29, 39] . Research in multiethnic settings with high levels of DDE is needed to confirm this hypothesis.
Genetic polymorphisms
In addition to mimicking estrogen activity, OCs are inducers of detoxification and drug-metabolizing enzymes [76, 77] . Variation in genotypes for drug-metabolism genotypes such as cytochrome P4501A1 (CYP1A1) and detoxification enzymes such as glutathione-S-transferase µ (GSTM1) may be associated with susceptibility to OCs. Moysich et al. [76] found elevated breast cancer risk among subjects with high total PCBs and either heterozygous (isoleucine: valine) or homozygous valine subtypes for CYP1A1. Compared to the isoleucine homozygous group with low PCBs, this group was 2.9 times more likely to have breast cancer after multivariate adjustment (95 % CI 1.2-7.5). For the isoleucine homozygous group with high PCB exposure, the OR was 1.08 (CI 0.6-1.9). However, Helzsouer et al. [35] did not find strong evidence of modified susceptibility to the effects of DDE or total PCBs associated with polymorphisms in GSTM1, GSTT1, GSTP1, COMT, or CYP17.
OCCUPATIONAL STUDIES
Few studies on occupational exposure and breast cancer among women have been published. Both the exposure route and the estrogenicity of isomers to which women are exposed occupationally are likely to differ substantially from food-borne exposure to persistent OCs. Studies of pesticide workers have not reported an increased breast cancer incidence or mortality cancer associated with this industry ( [78, 79] ; earlier studies reviewed by Adami et al. [80] ). While farmworking per se was not associated with increased risk, Duell et al. [21] reported increased risk of breast cancer associated with women who were present in fields during or shortly after pesticide application (OR = 1.8, 95 % CI = 1.1-2.8). Risk was also elevated among women who reported not using protective clothing while applying pesticides (OR = 2.0; 95 % CI = 1.0-4.3) but not among those who reported using protective clothing (OR = 0.8; 95 % CI = 0.4-1.8). As no consistent exposure-related effects are seen in other studies, this may reflect other farm-based exposures or characteristics of the lifestyle, rather than OC exposure.
OCS AND BREAST CANCER SEVERITY AND PROGRESSION
Although laboratory data suggest that OCs may act as tumor promoters [16] , the hypothesis that OCs may be related to the progression rather than the incidence of breast cancer has been explored in very few studies, so less is known on this topic [51] . Associations with various measures of stage, aggressiveness, and tumor markers have been reported in six studies to date (see Table 7 ). These studies-all M. A. MENDEZ AND L. ARAB Table 7 Organochlorines and breast cancer survival, severity, and progression. Notes: Demers [51] : Stronger associations also found for DDE using combined tumor size and lymph node involvement as marker of severity. Millikan [45] also examined associations stratified by stage at diagnosis and reported no differences in associations (results not shown). Zheng [52] also reported no association between TN and OCD and breast cancer histology or stage at diagnosis (data not shown).
conducted in industrialized countries using recent OC samples-have not reported associations between DDT/DDE and breast cancer survival, stage, aggressiveness, or tumor marker (p53 or erbB-2) [45, 51, 53, 81] . Positive associations with PCBs and various measures of progression, severity, or survival have been reported in some studies [51, 81] , but weak or null associations have been reported in other [43, 45, 52, 53] studies. Gammon et al. [54] did not find positive associations between stage at diagnosis (in situ vs. invasive disease) and concentrations of DDE, PCBs, or chlordane. Limited data suggest that other OCs may be associated with severity [51] and survival [81] . More data are needed before conclusions can be drawn, but this is an area deserving further study.
SUMMARY AND RECOMMENDATIONS
The sum of the evidence does not implicate any OC compound as significantly related to risk of occurrence of breast cancer. The evidence base is greatest for DDT and DDE. More limited research has been done on individual PCBs and their isomers. The studies of OC exposure reflect current exposure levels of chemicals that may have been banned for 20 years. Despite long half-lives (of 10 years) in adipose tissue, samples were generally collected 30 years after the peak exposure times. However, given ongoing exposure to persistent, nonestrogenic metabolites in foods, it is not certain that ranking of exposures using these samples is an accurate measure of past exposure to those compounds thought to increase risk.
More studies are needed on OCs other than DDTs in developing countries where use is more recent or continuing, especially given that most estrogenic OCs are not persistent. The possibility that OC exposure in excess of certain thresholds may be related to risk cannot be ruled out based on existing data. It is possible that other pathways that influence susceptibility may be involved, including activity related to CYP and GST; limited research is available to date on this hypothesis. Additionally, the BMI/weight loss model may warrant further analysis, perhaps using existing data.
OC exposures cannot reliably be related to trends in breast cancer incidence, as other known risk factors for breast cancer, such as childbearing and lactation. Changes in screening and treatment over time also complicate making such links. Ecologic data relating high-exposure countries to breast cancer mortality rates do not suggest a strong link. As noted by Rogan [82] , "in general, breast cancer rates are not higher in parts of the world with high DDE levels (the People's Republic of China, India, and Guatemala), and countries with relatively similar levels of PCBs (Great Britain and Japan) have very different breast cancer rates."
Although the information is extremely limited and not without major design flaws, the association between disease severity and progression is interesting and worthy of further examination.
As OCs are present in the environment as mixtures of correlated isomers and metabolites, it may be difficult to distinguish possible causal links from associations in which measured compounds are merely markers of other underlying exposures. Few studies [23, 36, 40, 52, 83] have reported adjusting for other OCs. For highly correlated compounds, traditional adjustment strategies may not be feasible. More complex analytical strategies, such as those used by Holford et al. [83] , may help to isolate potentially relevant isomers.
